SECOND AMENDED AND RESTATED CONSULTING AGREEMENT FOR NON-EMPLOYEE CHIEF EXECUTIVE OFFICERConsulting Agreement • October 31st, 2024 • Elevai Labs Inc. • Pharmaceutical preparations • British Columbia
Contract Type FiledOctober 31st, 2024 Company Industry JurisdictionThis Second Amended and Restated Consulting Agreement (this “Agreement”), effective as of October 25, 2024 (“Effective Date”), is entered into by and between Elevai Labs Inc., a Delaware corporation fka Reactive Medical Labs, Inc. (“Company”), and GB Capital Ltd, a British Columbia, Canada Corporation (“Consultant”).